A role for photoreceptors in retinal oedema and angiogenesis: An additional explanation for laser treatment

Eye

Volumn 24, Issue 5, 2010, Pages 918-926

  Foulds, W S ^a,b,c   Kaur, C ^a,d   Luu, C D ^a,b,e   Kek, W K ^a  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Neovascularisation; Photoreceptors; Retinal hypoxia; Retinal oedema

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; NITRIC OXIDE SYNTHASE; NITROGEN; OXYGEN; RHODIUM ISOTHIOCYANATE; SOMATOMEDIN C; TRACER; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL EMBOLISM; ASTROCYTE; BLOOD RETINA BARRIER; CONTROLLED STUDY; GLIA CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; LOW LEVEL LASER THERAPY; MUELLER CELL; NONHUMAN; PHOTORECEPTOR; RAT; RETINA CAPILLARY; RETINA CELL; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE; UPREGULATION; WESTERN BLOTTING;

EID: 77952473398     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2009.173     Document Type: Article

References (54)

1. Patz A. Clinical and experimental studies on retinal neovascularisation. XXXIX Edward Jackson Memorial Lecture. Am J Ophthalmol 1983;94:715-743.
2. Pe'er J, Shweiki D, Itin A, Hemo I, Gnessin H, Keshet E. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest 1995;72:638-645.
3. Joussen AM, Fauser S, Krohne TU, Lemmen KD, Lang GE, Kirchof B. Diabetic retinopathy: pathophysiology and therapy of hypoxia-induced inflammation. Ophthalmologe 2003;100:363-370.
4. Pournaras CJ, Tsacopoulos M, Strommer K, Gilodi N, Leuenberger PM. Experimental retinal branch retinal vein occlusion in miniature pigs induces local tissue hypoxia and vasoproliferative microangiopathy. Ophthalmology 1990;97:1321-1328. (Pubitemid 20353976)
5. Early Treatment of Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. ETDRS Report No. 1 Arch Ophthalmol 1985;103:1677-1682.
6. Schaal KB, Hoh AE, Scheuerle A, Schutt F, Dithmar S. Bevacizumab for the treatment of macular edema secondary to retinal vein occlusion. Ophthalmologe 2007;104:285-2897.
7. Scott IU, Edwards AR, Beck RW, Bressler NM, Chan CK, Elman MJ et al. Diabetic Retinopathy Clinical Research Network, A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology 2007;114:1860-1867.
8. Campochiaro PA, Hafiz G, Shah SM, Nguyen QD, Ying H, Do DV et al. Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. Mol Ther 2008;16:791-799.
9. Semenza GL. Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochem Pharmacol 2000;59:47-53.
10. Josko J, Mazurek M. Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis. Med Sci Monit 2004;10: RA89-RA98.
11. Wilkinson-Berka JL. Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cyclooxygenase-2 and nitric oxide. Curr Pharm Des 2004;10:3331-3348.
12. Kaur C, Sivakumar V, Foulds WS. Early response of neurons and glial cells to hypoxia in the retina. Invest Ophthalmol Vis Sci 2006;47:1126-1141.
13. Dobrogowska DH, Lossinsky AS, Tarnawski M, Vorbrodt AW. Increased blood-brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor. J Neurocytol 1988;27:163-173.
14. Croll SD, Ransohoff RM, Cai N, Zhang Q, Martin FJ, Wei T et al. VEGF-mediated inflammation precedes angiogenesis in adult brain. Exp Neurol 2004;187:388-402.
15. Diabetic Retinopathy Study Group. Photocoagulation treatment of proliferative diabetic retinopathy: relationship of adverse treatment effects to retinopathy severity. Diabetic Retinopathy Study Report No. 5 Dev Ophthalmol 1981;2:248-261.
16. Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings. DRS Report Number 8 Ophthalmology 1981;88:583-600.
17. Early Treatment Diabetic Retinopathy Study Group.. ETDRS Report number 9 Early photocoagulation for diabetic retinopathy. Ophthalmology 1991;98:766-785.
18. Opsina LH, Lyons CJ, Matsuba C, Jan J, McCormick AQ. Argon laser for retinopathy of prematurity: long-term outcome. Eye 2005;18:1213-1218.
19. Kieselbach GF, Rambarter A, Baldissera I, Kralinger MT. Laser photocoagulation for retinopathy of prematurity: structural and functional outcome. Acta Ophthalmol Scand 2006;84:21-26.
20. Branch Vein Occlusion Study Group. Argon laser scatter photocoagulation for the prevention of neovascularisation and vitreous hemorrhage in branch vein occlusion. Arch Ophthalmol 1986;104:34-41.
21. Hayreh SS, Rubinstein L, Podhajsky P. Argon scatter photocoagulation in the treatment of branch retinal vein occlusion. A prospective clinical trial. Ophthalmologica 1993;206:1-14.
22. Meyer-Schwickerath G. Light coagulation, (Translated by Drance). Mosby: St Louis, 1960, p 114.
23. Dobree JH. Simple diabetic retinopathy. Evolution of lesions and therapeutic considerations. Br J Ophthalmol 1970;54:1-10.
24. Pournaras CJ, Tsacopoulos M, Strommer K, Gilodi N, Leuenberger PM. Scatter photocoagulation restores tissue hypoxia in experimental vasoproliferative microangiopathy in miniature pigs. Ophthalmology 1990;97:1329-1333. (Pubitemid 20353977)
25. Molner I, Poitry S, Tsacopoulos M, Gilodi N, Leuenberger PM. Effect of laser photocoagulation on oxygenation of the retina in miniature pigs. Invest Opththalmol Vis Sci 1985;26:1410-1414.
26. Stefánsson E, Hatchell DL, Fisher BL, Sutherland FS, Machemer R. Panretinal photocoagulation and retinal oxygenation in normal and diabetic cats. Am J Ophthalmol 1986;101:657-664, (PR Dest).
27. Budzynski E, Smith JH, Bryar P, Birol G, Linsenmeier RA. Effects of photocoagulation on intraretinal PO2 in the cat. Invest Ophthalmol Vis Sci 2008;49:380-389.
28. Stefánsson E, Machemer R, de Juan Jr E, McCuen 2nd BW, Peterson J. Retinal oxygenation and laser treatment in patients with diabetic retinopathy. Am J Ophthalmol 1992;113:36-38, (clin).
29. Funatsu H, Wilson CA, Berkowitz BA, Sonkin PL. A comparative study of the effects of argon and diode laser photocoagulation on retinal oxygenation. Graefes Arch Clin Exp Ophthalmol 1997;235:168-175.
30. Stefánsson E. The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmol Scand 2001;79:435-440.
31. Gottfredsdóttir MS, Stefánsson E, Jónasson F, Gíslason I. Retinal vasoconstriction after laser treatment for diabetic macular edema. Am J Ophthalmol 1993;115:64-67.
32. Stefánsson E. Oxygen and diabetic eye disease. Graefes Arch Clin Ophthalmol 1990;228:120-123.
33. Landers 3rd MB, Stefansson E, Wolbarsht ML. Panretinal photocoagulation and retinal oxygenation. Retina 1982;2:167-175.
34. Grunwald JE, Riva CE, Brucker AJ, Sinclair SH, Petrig BL. Effect of panretinal photocoagulation on retinal blood flow in proliferative diabetic retinopathy. Ophthalmology 1986;93:590-595.
35. Stefánsson E, Landers 3rd MB, Wolbarsht ML. Increased retinal oxygen supply following pan-retinal photocoagulation and vitrectomy. Trans Am Ophthalmol Soc 1981;79:307-334.
36. Luttrull JK, Musch DC, Spink CA. Subthreshold diode micropulse panretinal photocoagulation for diabetic retinopathy. Eye 2008;22:607-612.
37. Behzadian MA, Wang XL, Al-Shabrawey M, Caldwell RB. Effects of hypoxia on glial cell expression of angiogenesisregulating factors VEGF and TGFbeta. Glia 1998;24:216-225.
38. Eichler W, Yafai Y, Wiedemann P, Reichenbach A. Angiogenesis-related factors derived from retinal glial (Müller) cells in hypoxia. Neuroreport 2004;15:1633-1637. (Pubitemid 38971184)
39. Zhang Y, Sivakumar V, Ling E-A, Foulds WS, Kaur C. Insulin-like growth factors, angiopoetin-2, and pigment epithelium derived growth factor in hypoxic retina. J Neuroscience Res 2008;86:702-711.
40. Kaur C, Sivakumar V, Yong Z, Foulds WS, Ling EA. Blood-retinal barrier disruption and ultrastructural changes in the hypoxic retina of adult rats: the beneficial effect of melatonin administration. J Pathol 2008;212:429-439.
41. Kaur C, Foulds WS, Ling EA. Hypoxia-ischemia and retinal ganglion cell damage. Clin Ophthalmol 2008;2:879-889.
42. Kaur C, Foulds WS, Ling EA. Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog Ret Eye Res 2008;27:622-647.
43. Linsenmeier RA, Braun RD. Oxygen distribution and consumption in the cat retina in normoxia and hypoxemia. J Gen Physiol 1992;99:177-197.
44. Cringle SJ, Yu DY, Alder V, Su EN. Light and choroidal PO2 modulation of intraretinal oxygen levels in an avascular retina. Invest Ophthalmol Vis Sci 1999;40:2307-2313.
45. Yu DY, Cringle SJ, Yu PK, Su EN. Intraretinal oxygen distribution and consumption during retinal artery occlusion and graded hyperoxic ventilation in the rat. Invest Ophthalmol Vis Sci 2007;48:2290-229647.
46. Wangsa-Wirawan ND, Linsenmeier RA. Retinal oxygen: fundamental and clinical aspects. Arch Ophthalmol 2003;121:547-557.
47. Braun RD, Linsenmeier RA, Goldstick TK. Oxygen consumption in the inner and outer retina of the cat. Invest Ophthalmol Vis Sci 1995;36:542-554.
48. Cringle SJ, Yu DY, Yu PK, Su EN. Intraretinal oxygen consumption in the rat in vivo. Invest Ophthalmol Vis Sci 2002;43:1922-1927.
49. Birol G, Wang S, Budzynski E, Wangsa-Wirawan ND, Linsenmeier RA. Oxygen distribution and consumption in the macaque retina. Am J Physiol Heart Circ Physiol 2007;293: H1696-H1704. (Pubitemid 47367217)
50. Johnson NF, McNaught EI, Foulds WS. Effect of photocoagulation on the barrier function of the pigment epithelium. II A study by electron microscopy. Trans Ophthal Soc UK 1977;97:640-651.
51. McNaught EI, Foulds WS, Johnson NF. The permeability of the posterior blood ocular barrier after xenon photocoagulation: a study using fluorescein labelled dextrans. Br J Ophthalmol 1981;65:473-477.
52. Inoue M, Tsukahara Y, Shirabe H, Yamamoto M. Disruption of the blood-aqueous barrier following retinal laser photocoagulation and cryopexy in pigmented rabbits. Ophthalmic Res 2001;33:37-41.
53. Foulds WS. The clinical significance of trans-scleral fluid transfer. Trans Ophthal Soc UK 1976;96:290-308.
54. Foulds WS, Moseley H, Eadie A, McNaught E. Vitreal, retinal and pigment epithelial contributions to the posterior blood ocular barrier. Trans Ophthal Soc UK 1980;100:341-342.